Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Blood eosinophil count in the general population: typical values and potential confounders.

Hartl S, Breyer MK, Burghuber OC, Ofenheimer A, Schrott A, Urban MH, Agusti A, Studnicka M, Wouters EFM, Breyer-Kohansal R.

Eur Respir J. 2020 Feb 14. pii: 1901874. doi: 10.1183/13993003.01874-2019. [Epub ahead of print]

PMID:
32060069
2.

COPD: Should Diagnosis Match Physiology?

Studnicka M, Horner A, Sator L, Buist AS, Lamprecht B; BOLD Collaborative Research Group.

Chest. 2020 Feb;157(2):473-475. doi: 10.1016/j.chest.2019.09.039. No abstract available.

PMID:
32033652
3.

Marked differences in prediabetes- and diabetes-associated comorbidities between men and women-Epidemiological results from a general population-based cohort aged 6-80 years-The LEAD (Lung, hEart, sociAl, boDy) study.

Breyer MK, Ofenheimer A, Altziebler J, Hartl S, Burghuber OC, Studnicka M, Purin D, Heinzle C, Drexel H, Franssen FME, Wouters EFM, Harreiter J, Kautzky-Willer A, Breyer-Kohansal R.

Eur J Clin Invest. 2020 Jan 29:e13207. doi: 10.1111/eci.13207. [Epub ahead of print]

PMID:
31997311
4.

The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis.

Tran T, Šterclová M, Mogulkoc N, Lewandowska K, Müller V, Hájková M, Kramer MR, Jovanović D, Tekavec-Trkanjec J, Studnicka M, Stoeva N, Hejduk K, Dušek L, Suissa S, Vašáková M; EMPIRE registry.

Respir Res. 2020 Jan 8;21(1):11. doi: 10.1186/s12931-019-1271-z.

5.

Pulmonary function decreases moderately after accelerated high-dose irradiation for stage III non-small cell lung cancer.

Grambozov B, Wolf F, Kaiser J, Wass R, Fastner G, Gaisberger C, Rettenbacher L, Studnicka M, Pirich C, Sedlmayer F, Zehentmayr F.

Thorac Cancer. 2020 Feb;11(2):369-378. doi: 10.1111/1759-7714.13276. Epub 2019 Dec 19.

6.

Airflow Obstruction and Cardio-metabolic Comorbidities.

Triest FJJ, Studnicka M, Franssen FME, Vollmer WM, Lamprecht B, Wouters EFM, Burney PGJ, Vanfleteren LEGW.

COPD. 2019 Apr;16(2):109-117. doi: 10.1080/15412555.2019.1614550. Epub 2019 May 27.

7.

Overdiagnosis of COPD in Subjects With Unobstructed Spirometry: A BOLD Analysis.

Sator L, Horner A, Studnicka M, Lamprecht B, Kaiser B, McBurnie MA, Buist AS, Gnatiuc L, Mannino DM, Janson C, Bateman ED, Burney P; BOLD Collaborative Research Group.

Chest. 2019 Aug;156(2):277-288. doi: 10.1016/j.chest.2019.01.015. Epub 2019 Jan 31.

8.

The European COPD audit : Adherence to guidelines, readmission risk and hospital care for acute exacerbations in Austria.

Breyer-Kohansal R, Hartl S, Breyer MK, Schrott A, Studnicka M, Neunhäuserer D, Fülöp G, Burghuber OC.

Wien Klin Wochenschr. 2019 Mar;131(5-6):97-103. doi: 10.1007/s00508-019-1441-5. Epub 2019 Jan 28.

PMID:
30689047
9.

Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation.

Zehentmayr F, Sprenger M, Rettenbacher L, Wass R, Porsch P, Fastner G, Pirich C, Studnicka M, Sedlmayer F.

Thorac Cancer. 2019 Feb;10(2):321-329. doi: 10.1111/1759-7714.12966. Epub 2019 Jan 7.

10.

The LEAD (Lung, Heart, Social, Body) Study: Objectives, Methodology, and External Validity of the Population-Based Cohort Study.

Breyer-Kohansal R, Hartl S, Burghuber OC, Urban M, Schrott A, Agusti A, Sigsgaard T, Vogelmeier C, Wouters E, Studnicka M, Breyer MK.

J Epidemiol. 2019 Aug 5;29(8):315-324. doi: 10.2188/jea.JE20180039. Epub 2018 Oct 20.

11.

Multiprofessional COPD care in Austria-challenges and approaches : Results of a qualitative study.

Sari Kundt F, Enthaler N, Dieplinger AM, Studnicka M, Knoll A, Osterbrink J, Johansson T, Flamm M.

Wien Klin Wochenschr. 2018 Jun;130(11-12):371-381. doi: 10.1007/s00508-018-1346-8. Epub 2018 May 28.

12.

[Guideline for the Diagnosis and Treatment of COPD Patients - Issued by the German Respiratory Society and the German Atemwegsliga in Cooperation with the Austrian Society of Pneumology].

Vogelmeier C, Buhl R, Burghuber O, Criée CP, Ewig S, Godnic-Cvar J, Hartl S, Herth F, Kardos P, Kenn K, Nowak D, Rabe KF, Studnicka M, Watz H, Welte T, Windisch W, Worth H; unter Mitwirkung der folgenden wissenschaftlichen Fachgesellschaften: Deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin e.V. ; Deutsche Gesellschaft für Rehabilitationswissenschaften e.V.

Pneumologie. 2018 Apr;72(4):253-308. doi: 10.1055/s-0043-125031. Epub 2018 Mar 9. German.

PMID:
29523017
13.

Fatal Necrotizing Encephalopathy after Treatment with Nivolumab for Squamous Non-Small Cell Lung Cancer: Case Report and Review of the Literature.

Leitinger M, Varosanec MV, Pikija S, Wass RE, Bandke D, Weis S, Studnicka M, Grinzinger S, McCoy MR, Hauer L, Sellner J.

Front Immunol. 2018 Jan 30;9:108. doi: 10.3389/fimmu.2018.00108. eCollection 2018. Review.

14.

Unemployment in chronic airflow obstruction around the world: results from the BOLD study.

Grønseth R, Erdal M, Tan WC, Obaseki DO, Amaral AFS, Gislason T, Juvekar SK, Koul PA, Studnicka M, Salvi S, Burney P, Buist AS, Vollmer WM, Johannessen A; Research teams at centres.

Eur Respir J. 2017 Sep 20;50(3). pii: 1700499. doi: 10.1183/13993003.00499-2017. Print 2017 Sep.

15.

Airflow Obstruction and Use of Solid Fuels for Cooking or Heating: BOLD Results.

Amaral AFS, Patel J, Kato BS, Obaseki DO, Lawin H, Tan WC, Juvekar SK, Harrabi I, Studnicka M, Wouters EFM, Loh LC, Bateman ED, Mortimer K, Buist AS, Burney PGJ; BOLD Collaborative Research Group.

Am J Respir Crit Care Med. 2018 Mar 1;197(5):595-610. doi: 10.1164/rccm.201701-0205OC. Epub 2017 Sep 12.

16.

Altitude and COPD prevalence: analysis of the PREPOCOL-PLATINO-BOLD-EPI-SCAN study.

Horner A, Soriano JB, Puhan MA, Studnicka M, Kaiser B, Vanfleteren LEGW, Gnatiuc L, Burney P, Miravitlles M, García-Rio F, Ancochea J, Menezes AM, Perez-Padilla R, Montes de Oca M, Torres-Duque CA, Caballero A, González-García M, Buist S, Flamm M, Lamprecht B; BOLD Collaborative Research Group; EPI-SCAN Team; PLATINO Team; PREPOCOL Study Group.

Respir Res. 2017 Aug 23;18(1):162. doi: 10.1186/s12931-017-0643-5.

17.

Role of Breathing Conditions During Exercise Testing on Training Prescription in Chronic Obstructive Pulmonary Disease.

Neunhäuserer D, Steidle-Kloc E, Bergamin M, Weiss G, Ermolao A, Lamprecht B, Studnicka M, Niebauer J.

Am J Phys Med Rehabil. 2017 Dec;96(12):908-911. doi: 10.1097/PHM.0000000000000775.

PMID:
28644243
18.

Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study.

Weiss G, Steinacher I, Lamprecht B, Kaiser B, Mikes R, Sator L, Hartl S, Wagner H, Studnicka M.

NPJ Prim Care Respir Med. 2017 Jan 26;27(1):4. doi: 10.1038/s41533-016-0005-7.

19.

DART-bid for loco-regionally advanced NSCLC : Summary of acute and late toxicity with long-term follow-up; experiences with pulmonary dose constraints.

Wurstbauer K, Zehentmayr F, Deutschmann H, Dagn K, Exeli AK, Kopp P, Porsch P, Maurer B, Studnicka M, Sedlmayer F.

Strahlenther Onkol. 2017 Apr;193(4):315-323. doi: 10.1007/s00066-016-1095-4. Epub 2017 Jan 23.

20.

Supplemental Oxygen During High-Intensity Exercise Training in Nonhypoxemic Chronic Obstructive Pulmonary Disease.

Neunhäuserer D, Steidle-Kloc E, Weiss G, Kaiser B, Niederseer D, Hartl S, Tschentscher M, Egger A, Schönfelder M, Lamprecht B, Studnicka M, Niebauer J.

Am J Med. 2016 Nov;129(11):1185-1193. doi: 10.1016/j.amjmed.2016.06.023. Epub 2016 Jul 15.

PMID:
27427325
21.

Management of malignant pleural mesothelioma - part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) database.

Klikovits T, Hoda MA, Dong Y, Arns M, Baumgartner B, Errhalt P, Geltner C, Machan B, Pohl W, Hutter J, Eckmayr J, Studnicka M, Flicker M, Cerkl P, Kirchbacher K, Klepetko W.

Wien Klin Wochenschr. 2016 Sep;128(17-18):627-34. doi: 10.1007/s00508-016-1037-2. Epub 2016 Jul 25.

22.

Management of malignant pleural mesothelioma-part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG).

Hoda MA, Klikovits T, Arns M, Dieckmann K, Zöchbauer-Müller S, Geltner C, Baumgartner B, Errhalt P, Machan B, Pohl W, Hutter J, Eckmayr J, Studnicka M, Flicker M, Cerkl P, Klepetko W.

Wien Klin Wochenschr. 2016 Sep;128(17-18):618-26. doi: 10.1007/s00508-016-1036-3. Epub 2016 Jul 25.

23.

Diagnosis and management of asthma - Statement on the 2015 GINA Guidelines.

Horak F, Doberer D, Eber E, Horak E, Pohl W, Riedler J, Szépfalusi Z, Wantke F, Zacharasiewicz A, Studnicka M.

Wien Klin Wochenschr. 2016 Aug;128(15-16):541-54. doi: 10.1007/s00508-016-1019-4. Epub 2016 Jul 1.

24.

Diagnostic performance of [18F] FDG PET-CT compared to bone scintigraphy for the detection of bone metastases in lung cancer patients.

Rodrigues M, Stark H, Rendl G, Rettenbacher L, Datz L, Studnicka M, Pirich C.

Q J Nucl Med Mol Imaging. 2016 Mar;60(1):62-8.

PMID:
26844431
25.

Body mass index and chronic airflow limitation in a worldwide population-based study.

Vanfleteren LE, Lamprecht B, Studnicka M, Kaiser B, Gnatiuc L, Burney P, Wouters EF, Franssen FM.

Chron Respir Dis. 2016 May;13(2):90-101. doi: 10.1177/1479972315626012. Epub 2016 Jan 14.

26.

Lung function defects in treated pulmonary tuberculosis patients.

Amaral AF, Coton S, Kato B, Tan WC, Studnicka M, Janson C, Gislason T, Mannino D, Bateman ED, Buist S, Burney PG; BOLD Collaborative Research Group.

Eur Respir J. 2016 Jan;47(1):352-3. doi: 10.1183/13993003.01366-2015. No abstract available.

27.

First line crizotinib in anaplastic lymphoma kinase (ALK) rearranged squamous cell lung cancer.

Mikes RE, Jordan F, Hutarew G, Studnicka M.

Lung Cancer. 2015 Dec;90(3):614-6. doi: 10.1016/j.lungcan.2015.10.013. Epub 2015 Oct 16.

PMID:
26519123
28.

Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit.

Hartl S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, Studnicka M, Kaiser B, Roberts CM.

Eur Respir J. 2016 Jan;47(1):113-21. doi: 10.1183/13993003.01391-2014. Epub 2015 Oct 22.

29.

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results.

Amaral AF, Coton S, Kato B, Tan WC, Studnicka M, Janson C, Gislason T, Mannino D, Bateman ED, Buist S, Burney PG; BOLD Collaborative Research Group.

Eur Respir J. 2015 Oct;46(4):1104-12. doi: 10.1183/13993003.02325-2014. Epub 2015 Jun 25.

30.

Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).

Zehentmayr F, Söhn M, Exeli AK, Wurstbauer K, Tröller A, Deutschmann H, Fastner G, Fussl C, Steininger P, Kranzinger M, Belka C, Studnicka M, Sedlmayer F.

Radiat Oncol. 2015 May 28;10:121. doi: 10.1186/s13014-015-0429-1.

31.

Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation.

Grabcanovic-Musija F, Obermayer A, Stoiber W, Krautgartner WD, Steinbacher P, Winterberg N, Bathke AC, Klappacher M, Studnicka M.

Respir Res. 2015 May 22;16:59. doi: 10.1186/s12931-015-0221-7.

32.

Determinants of underdiagnosis of COPD in national and international surveys.

Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren LE, Gnatiuc L, Burney P, Miravitlles M, García-Rio F, Akbari K, Ancochea J, Menezes AM, Perez-Padilla R, Montes de Oca M, Torres-Duque CA, Caballero A, González-García M, Buist S; BOLD Collaborative Research Group, the EPI-SCAN Team, the PLATINO Team, and the PREPOCOL Study Group.

Chest. 2015 Oct;148(4):971-985. doi: 10.1378/chest.14-2535.

PMID:
25950276
33.

Symptomatic chronic obstructive pulmonary disease in clinical trials and in a population-based study.

Niederseer D, Richter SA, Neunhäuserer D, Lamprecht B, Buist SA, Studnicka M, Niebauer J.

Sleep Breath. 2015 Sep;19(3):801-8. doi: 10.1007/s11325-014-1087-5. Epub 2014 Nov 27.

PMID:
25427819
34.

DART-bid: dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily: high local control in early stage (I/II) non-small-cell lung cancer.

Zehentmayr F, Wurstbauer K, Deutschmann H, Fussl C, Kopp P, Dagn K, Fastner G, Porsch P, Studnicka M, Sedlmayer F.

Strahlenther Onkol. 2015 Mar;191(3):256-63. doi: 10.1007/s00066-014-0754-6. Epub 2014 Sep 23.

PMID:
25245469
35.

ROS1 mutation and treatment with crizotinib in a 30-year old Caucasian woman with stage IV non-small cell lung cancer/adenocarcinoma and complete remission.

Blaukovitsch M, Hofer J, Hutarew G, Müllauer L, Ingrid SK, Studnicka M.

Thorac Cancer. 2014 Sep;5(5):455-9. doi: 10.1111/1759-7714.12106. Epub 2014 Aug 25.

36.

New aspects on the structure of neutrophil extracellular traps from chronic obstructive pulmonary disease and in vitro generation.

Obermayer A, Stoiber W, Krautgartner WD, Klappacher M, Kofler B, Steinbacher P, Vitkov L, Grabcanovic-Musija F, Studnicka M.

PLoS One. 2014 May 15;9(5):e97784. doi: 10.1371/journal.pone.0097784. eCollection 2014.

37.

Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty: a BOLD analysis--authors' reply.

Burney P, Kato B, Janson C, Mannino D, Studnicka M, Tan W, Bateman E, Koçabas A, Vollmer WM, Gislason T, Marks G, Koul PA, Gnatiuc L, Buist S; Burden of Obstructive Lung Disease (BOLD) Study.

Thorax. 2014 Sep;69(9):869-70. doi: 10.1136/thoraxjnl-2014-205474. Epub 2014 May 1. No abstract available.

PMID:
24789424
38.

Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty--a BOLD analysis.

Burney P, Jithoo A, Kato B, Janson C, Mannino D, Nizankowska-Mogilnicka E, Studnicka M, Tan W, Bateman E, Koçabas A, Vollmer WM, Gislason T, Marks G, Koul PA, Harrabi I, Gnatiuc L, Buist S; Burden of Obstructive Lung Disease (BOLD) Study.

Thorax. 2014 May;69(5):465-73. doi: 10.1136/thoraxjnl-2013-204460. Epub 2013 Dec 18.

39.

Detection of chronic obstructive pulmonary disease in primary care in Salzburg, Austria: findings from the real world.

Weiss G, Steinacher I, Lamprecht B, Schirnhofer L, Kaiser B, Sönnichsen A, Studnicka M.

Respiration. 2014;87(2):136-43. doi: 10.1159/000354796. Epub 2013 Nov 28.

40.

Docetaxel in the treatment of non-small cell lung cancer (NSCLC) -- an observational study focusing on symptom improvement.

Pircher A, Wasle IK, Mian M, Gamerith G, Ulsperger E, Studnicka M, Mohn-Staudner A, Hilbe W, Fiegl M.

Anticancer Res. 2013 Sep;33(9):3831-6.

PMID:
24023316
41.

Sex-related differences in respiratory symptoms: results from the BOLD Study.

Lamprecht B, Vanfleteren LE, Studnicka M, Allison M, McBurnie MA, Vollmer WM, Tan WC, Nielsen R, Nastalek P, Gnatiuc L, Kaiser B, Janson C, Wouters EF, Burney P, Buist AS; BOLD Collaborative Research Group.

Eur Respir J. 2013 Sep;42(3):858-60. doi: 10.1183/09031936.00047613. No abstract available.

42.

The impact of COPD on health status: findings from the BOLD study.

Janson C, Marks G, Buist S, Gnatiuc L, Gislason T, McBurnie MA, Nielsen R, Studnicka M, Toelle B, Benediktsdottir B, Burney P.

Eur Respir J. 2013 Dec;42(6):1472-83. doi: 10.1183/09031936.00153712. Epub 2013 May 30.

43.

[Opinion of the Austrian Society of Radiology and the Austrian Society of Pneumology].

Prosch H, Studnicka M, Eisenhuber E, Olschewski H, Stiefsohn E, Hartl S, Herold C, Burghuber O, Mostbeck G; Vorstände der Österreichischen Röntgengesellschaft, Gesellschaft für Medizinische Radiologie und Nuklearmedizin und der Österreichischen Gesellschaft für Pneumologie; Austrian Society of Radiology; Austrian Society of Pneumology.

Wien Klin Wochenschr. 2013 Jun;125(11-12):339-45. doi: 10.1007/s00508-013-0356-9. Epub 2013 May 15. German.

PMID:
23674050
44.

Is spirometry properly used to diagnose COPD? Results from the BOLD study in Salzburg, Austria: a population-based analytical study.

Lamprecht B, Mahringer A, Soriano JB, Kaiser B, Buist AS, Studnicka M.

Prim Care Respir J. 2013 Jun;22(2):195-200. doi: 10.4104/pcrj.2013.00032.

45.

DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.

Wurstbauer K, Deutschmann H, Dagn K, Kopp P, Zehentmayr F, Lamprecht B, Porsch P, Wegleitner B, Studnicka M, Sedlmayer F.

Radiat Oncol. 2013 Mar 5;8:49. doi: 10.1186/1748-717X-8-49.

46.

Pegfilgrastim prophylaxis in patients at different levels of risk for chemotherapy-associated febrile neutropenia: an observational study.

Fiegl M, Steger GG, Studnicka M, Eisterer W, Jaeger C, Willenbacher W.

Curr Med Res Opin. 2013 May;29(5):505-15. doi: 10.1185/03007995.2013.781018. Epub 2013 Mar 19.

PMID:
23444969
47.

Case-finding options for COPD: results from the Burden of Obstructive Lung Disease study.

Jithoo A, Enright PL, Burney P, Buist AS, Bateman ED, Tan WC, Studnicka M, Mejza F, Gillespie S, Vollmer WM; BOLD Collaborative Research Group.

Eur Respir J. 2013 Mar;41(3):548-55. doi: 10.1183/09031936.00132011. Epub 2012 Jun 27.

48.

The impact of PET and PET/CT on treatment planning and prognosis of patients with NSCLC treated with radiation therapy.

Nawara C, Rendl G, Wurstbauer K, Lackner B, Rettenbacher L, Datz L, Studnicka M, Sedlmayer F, Pirich C.

Q J Nucl Med Mol Imaging. 2012 Apr;56(2):191-201. Epub 2012 Mar 9.

PMID:
22402822
49.

Electromagnetic navigation bronchoscopy (ENB): Increasing diagnostic yield.

Lamprecht B, Porsch P, Wegleitner B, Strasser G, Kaiser B, Studnicka M.

Respir Med. 2012 May;106(5):710-5. doi: 10.1016/j.rmed.2012.02.002. Epub 2012 Mar 3.

50.

Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy.

Manzenreiter R, Kienberger F, Marcos V, Schilcher K, Krautgartner WD, Obermayer A, Huml M, Stoiber W, Hector A, Griese M, Hannig M, Studnicka M, Vitkov L, Hartl D.

J Cyst Fibros. 2012 Mar;11(2):84-92. doi: 10.1016/j.jcf.2011.09.008. Epub 2011 Oct 12.

Supplemental Content

Loading ...
Support Center